Contact: Dacia Morris
(212) 543-5421
morrisd@pi.cpmc.columbia.edu

 

DIFFERENCES IN CEREBAL BLOOD FLOW SEEN IN SCHIZOPHRENIA SUBGROUPS
New Approaches to Research & Treatment May Be Needed

New York, NY (December 15)—According to a study in today’s Biological Psychiatry, researchers have shown for the first time that differences in resting brain activity distinguish two distinct schizophrenia subgroups, namely those with a family history of the disease and those without.


Dr. Dolores Malaspina, the lead investigator and a research psychiatrist at the New York State Psychiatric Institute at Columbia University Medical Center, said that though the heterogeneity of schizophrenia patients is well-established and previous studies have shown symptomatic and physiologic differences between the subgroups, no other study has until now used neuroimaging to compare resting brain activity in the two groups.


She added, “Most current studies try to tease out the differences in brain activity by asking subjects to perform a cognitive task. However, differences one might find as a result may actually be masking the true fundamental markers that distinguish familial schizophrenia from non-familial schizophrenia.”

With this in mind, Dr. Malaspina and colleagues looked at brain activity among three groups: a group of 10 patients with a family history of schizophrenia, a group of 16 without a family history (sometimes referred to as sporadic schizophrenia) and a group of 9 healthy people. They all underwent SPECT imaging while at rest. (SPECT provides a highly accurate measure of blood flow in the brain.)


As they expected, both subgroups showed different resting blood flow patterns. More compelling, though, was evidence indicating decreased blood flow (decreased brain activity) in the familial group in regions associated with negative symptoms. According to the authors “Familial, but not sporadic, cases have treatment-resistant negative symptoms, particularly emotional withdrawal, poor rapport…whereas these symptoms improve with antipsychotic treatment in sporadic cases.” This seems to further support the view that familial and sporadic schizophrenia are indeed distinct subgroups each of which will require different research and treatment strategies to ensure positive outcomes. This study is another step towards understanding the poorly understood concept of sporadic schizophrenia.

 

Go Back to News Releases